Literature DB >> 32101674

Nivolumab plus Ipilimumab in Non-Small-Cell Lung Cancer. Reply.

Matthew D Hellmann1, Suresh S Ramalingam2.   

Abstract

Entities:  

Year:  2020        PMID： 32101674     DOI： 10.1056/NEJMc1916859

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Caspase-8 knockdown suppresses apoptosis, while induces autophagy and chemo-sensitivity in non-small cell lung cancer cells.

Authors:  Hui Zuo; Cheng Chen; Ling Ma; Qiu-Xia Min; Yue-Hai Shen
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

2.  Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients.

Authors:  Bart van Hoek; Ellen Kapiteijn; Maaike Biewenga; Monique K van der Kooij; Michel W J M Wouters; Maureen J B Aarts; Franchette W P J van den Berkmortel; Jan Willem B de Groot; Marye J Boers-Sonderen; Geke A P Hospers; Djura Piersma; Rozemarijn S van Rijn; Karijn P M Suijkerbuijk; Albert J Ten Tije; Astrid A M van der Veldt; Gerard Vreugdenhil; John B A G Haanen; Alfons J M van der Eertwegh
Journal:  Hepatol Int       Date:  2021-02-25       Impact factor: 6.047
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.